Reneo Pharmaceuticals is a pharmaceutical company focused on the development of therapies for patients with genetic mitochondrial diseases. It develops REN001, a selective peroxisome proliferator-activated receptor delta agonist, to treat rare diseases such as fatty acid oxidation disorders and primary mitochondrial myopathies.
|HQ||San Diego, CA, US||Map|
Net income (Q2, 2021)
EBIT (Q2, 2021)
Market capitalization (21-Oct-2021)
Closing stock price (21-Oct-2021)
|Company Name||Date||Deal Size|
|Reneo Pharma Ltd|
Reneo Pharmaceuticals has 83 Twitter Followers. The number of followers has increased 3.8% month over month and increased 7% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was Reneo Pharmaceuticals founded?
Reneo Pharmaceuticals was founded in 2018.
Who are Reneo Pharmaceuticals key executives?
Reneo Pharmaceuticals's key executives are Gregory J. Flesher, Mike Grey and Alejandro Dorenbaum.
How many employees does Reneo Pharmaceuticals have?
Reneo Pharmaceuticals has 17 employees.
Who are Reneo Pharmaceuticals competitors?
Competitors of Reneo Pharmaceuticals include IntraBio, Momotaro Gene and GeneQuine Biotherapeutics.
Where is Reneo Pharmaceuticals headquarters?
Reneo Pharmaceuticals headquarters is located at 12230 El Camino Real #230, San Diego.
Where are Reneo Pharmaceuticals offices?
Reneo Pharmaceuticals has offices in San Diego, Irvine and Sandwich.
How many offices does Reneo Pharmaceuticals have?
Reneo Pharmaceuticals has 3 offices.
Receive alerts for 300+ data fields across thousands of companies